DocGo Inc

DocGo Inc

DCGO · NASDAQ · Healthcare / Medical Care Facilities

0.2076USD-0.02 (-7.73%)

Price History

Full chart

Market Stats

Previous Close0.225
Open0.2277
Day Range0.2073 – 0.2277
52-Week Range0.3107 – 1.65
Volume789.25K
Market Cap33.64M
P/E (TTM)0.00
Forward P/E60.24
EPS-1.82
Dividend Yield0.00%
Beta0.94
50-Day Avg0.5059
200-Day Avg0.6497

About

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Lee Bienstock
  • Employees2.54K
  • Headquarters685 Third Avenue, New York, NY, United States, 10017, USA
  • Websitehttps://docgo.com

Leadership

  • Mr. Lee BienstockCEO & Director · b. 1985
  • Mr. Norman RosenbergTreasurer & CFO · b. 1970
  • Mr. Ely D. Tendler J.D.General Counsel, Secretary & Director · b. 1968
  • Mr. Eiwe LingeforsChief Information Officer
  • Mr. Mike ColeVice President of Investor Relations
  • Mr. Stephen SugrueChief Compliance Officer · b. 1973
  • Ms. Rosemarie MilanoVice President of Human Resources
  • Dr. James Powell M.D.CEO of Clinical Practice Group & Member of Medical Advisory Board

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue48.30M94.09M318.72M440.52M624.29M616.56M322.20M
Growth (%)-+94.81%+238.74%+38.21%+41.72%-1.24%-47.74%
Cost of Revenue35.11M62.74M208.97M285.79M428.91M402.98M223.44M
Gross Profit13.19M31.35M109.75M154.72M195.38M213.57M98.76M
Gross Margin27.31%33.32%34.43%35.12%31.30%34.64%30.65%
Operating Expense33.95M46.10M94.39M132.89M180.33M184.89M187.91M
Operating Income-20.76M-14.76M15.36M21.83M15.05M28.69M-89.16M
Operating Margin-42.99%-15.68%4.82%4.96%2.41%4.65%-27.67%
EBITDA-16.58M-9.25M28.07M33.35M32.73M45.56M-170.82M
EBITDA Margin-34.33%-9.83%8.81%7.57%5.24%7.39%-53.02%
Net Income-20.21M-14.36M23.74M34.58M6.86M19.99M-182.40M
Net Income Margin-41.84%-15.26%7.45%7.85%1.10%3.24%-56.61%
R&D1.22M1.19M3.32M5.38M10.86M11.59M13.56M
R&D as % of Total Revenue2.53%1.26%1.04%1.22%1.74%1.88%4.21%
Interest Expense717.32K204.63K763.03K762.68K1.68T2.17M1.01M
Interest Expense % of Total Revenue1.49%0.22%0.24%0.17%269810.93%0.35%0.31%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets100.96M100.17M309.60M393.28M490.45M455.62M217.10M
Total Liabilities21.60M33.23M82.55M114.35M185.28M140.44M91.23M
Total Equity68.47M55.00M227.06M273.23M300.79M320.92M144.01M
Cash47.74M32.42M175.54M157.34M59.29M89.24M51.02M
Total Debt15.54M13.89M20.18M19.91M46.50M57.19M29.18M
Net Debt-32.20M-18.53M-159.03M-137.42M-12.79M-32.05M-21.84M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-14.21M-10.65M-1.95M28.87M-64.22M70.34M34.45M
Investing Cash Flow-2.97M-6.04M-8.59M-38.45M-29.88M-10.87M-39.08M
Financing Cash Flow56.34M-812.09K155.21M-6.18M1.12M-24.15M-50.82M
Capital Expenditure3.80M6.32M6.66M5.50M10.13M5.84M7.43M
Free Cash Flow-18.01M-16.97M-8.60M23.37M-74.35M64.50M27.02M
Dividends Paid--8.63M--1.29T-
FCF to OCF126.77%159.28%441.86%80.96%115.77%91.70%78.42%
Dividend Paid to FCF---100.27%--2006830.27%-

Earnings

Report DateNov 25, 2020Mar 30, 2021Jun 3, 2021Aug 11, 2021Nov 15, 2021Mar 14, 2022May 9, 2022Aug 8, 2022Nov 7, 2022Mar 13, 2023May 8, 2023Aug 7, 2023Nov 6, 2023Feb 28, 2024May 8, 2024Aug 7, 2024Nov 7, 2024Feb 26, 2025May 8, 2025Aug 7, 2025Nov 10, 2025Mar 16, 2026May 11, 2026Aug 17, 2026Nov 9, 2026
EPS Estimate0.00---0.030.020.190.130.170.050.090.140.210.100.340.350.240.210.03-0.06-0.40-0.14-0.06-0.04-0.04
EPS Actual0.00-0.010.14-0.0499.280.230.380.490.120.010.080.060.230.070.470.290.250.05-0.17-0.11-0.25-1.68-0.330.16-
Surprise----330833.33%1050.00%100.00%276.92%-29.41%-80.00%-11.11%-57.14%9.52%-30.00%38.24%-17.14%4.17%-76.60%-666.67%-83.33%37.50%-1065.56%-450.00%500.00%-
Timing--After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap33.64M
Enterprise Value36.50M
Trailing P/E0.00
Forward P/E60.24
Price / Sales0.11
Price / Book0.30
EPS-1.82
Book Value1.20
Revenue (TTM)294.72M
Gross Profit (TTM)88.78M
EBITDA-81.05M
Profit Margin-65.29%
Operating Margin-24.41%
Return on Equity-107.79%
Return on Assets-19.81%
Shares Outstanding98.93M
Shares Float96.12M
Beta0.94
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 7 analystsTarget 1.88
  • Strong Buy
    3
  • Buy
    1
  • Hold
    3

Ownership Breakdown

Institutions
39.05%
Insiders
3.06%
Retail / Other
57.89%

Top Institutional Holders

  • BlackRock Inc
    6.37M6.43%
  • Vanguard Capital Management, LLC
    3.68M3.72%
  • P.a.w. Capital Corp
    3.50M3.54%
  • Knott David M Jr
    2.67M2.70%
  • Peapod Lane Capital LLC
    2.50M2.53%
  • Geode Capital Management, LLC
    2.41M2.44%
  • Citadel Advisors Llc
    2.35M2.38%
  • S Squared Technology, LLC
    2.06M2.08%
  • State Street Corp
    1.97M1.99%
  • Acadian Asset Management LLC
    1.52M1.54%
  • Renaissance Technologies Corp
    1.51M1.53%
  • Moore Capital Management, LP
    1.47M1.48%
  • ISTHMUS Partners LLC
    1.19M1.20%
  • The Goldman Sachs Group Inc
    1.01M1.02%
  • GSA Capital Partners LLP
    1.00M1.01%
  • Vanguard Portfolio Management, LLC
    779.26K0.79%
  • AQR Capital Management LLC
    735.26K0.74%
  • Northern Trust Corp
    697.79K0.71%
  • Charles Schwab Investment Management Inc
    672.89K0.68%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.66M2.69%